inclusion criteria: * adult patients, 18 years and above * sars-2-cov-2 infection, laboratory-confirmed * admission to the hospital ward or icu * written informed consent prior to initiation of the study or a close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when the patient is unable to give consent herself/himself. * no anticipated transfer within 72 hours to a non-study hospital

inclusion criteria: * adult patients, 18 years and above * sars-2-cov-2 infection, laboratory-confirmed * admission to the hospital ward or icu * written informed consent prior to initiation of the study or a close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when the patient is unable to give consent herself/himself. * no anticipated transfer within 72 hours to a non-study hospital

inclusion criteria: adult patients, 18 years and above sars-2-cov-2 infection, laboratory-confirmed admission to the hospital ward or icu written informed consent prior to initiation of the study or a close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when the patient is unable to give consent herself/himself. no anticipated transfer within 72 hours to a non-study hospital

inclusion criteria: adult patients, 18 years and above sars-2-cov-2 infection, laboratory-confirmed admission to the hospital ward or icu written informed consent prior to initiation of the study or a close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when the patient is unable to give consent herself/himself. no anticipated transfer within 72 hours to a non-study hospital